Clinical Trial Update: Investigation of Intravenous (IV) Administration of an Approved Drug (MK-0476, Montelukast Sodium) for Acute Asthma (MK-0476-288) [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 trial evaluating intravenous montelukast (MK-0476) for acute asthma. The trial was sponsored by Organon and Co.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Montelukast Sodium (Montelukast Sodium)

Snippet

Sponsor: Organon and Co | Conditions: Asthma | Phase 3 | Status: COMPLETED